Literature DB >> 23879277

Potential prevention of pacing-induced heart failure using simple pacemaker programming algorithm.

Tomasz Chwyczko1, Rafał Dąbrowski, Aleksander Maciąg, Maciej Sterliński, Edyta Smolis-Bąk, Anna Borowiec, Ilona Kowalik, Andrada Łabęcka, Agnieszka Jankowska, Marek Kośmicki, Jadwiga Janas, Mariusz Pytkowski, Hanna Szwed.   

Abstract

INTRODUCTION: Right ventricular pacing (RVP) causes ventricular desynchronization and may lead to the development of heart failure (HF). Prolongation of atrioventricular delay (AVD) in DDDR pacemakers reduces unnecessary RV stimulation. The aim of the study was to verify the influence of RVP reduction on HF symptoms.
METHODS: The study comprised 31 patients (17 men, mean age: 71.6 ± 8 yrs) with DDDR pacemaker implanted due to sinus node dysfunction (SND). At baseline, 28 patients did not present any symptoms of HF. Three patients were in NYHA class II. Patients were randomized either to 150 ms AVD or to minimizing right ventricular pacing (MRVP). Crossing over to the alternate mode took place after 4 months. Cardiopulmonary exercise test (CPX), echocardiography (ECHO) and BNP measurements were done before pacemaker implantation, after 4 and 8 months.
RESULTS: The percentage of RVP was significantly higher in 150 ms AVD than in MRVP: 81.7 ± 22.6 versus 14.2±20.5%, P < 0.0001. Patients with 150 ms mode had worse CPX parameters than those with MRVP mode: peak oxygen uptake was 14.2±4.3 versus 19.9±6.3 ml/kg per min, P = 0.0001, higher BNP concentrations: 72.3±48.3 versus 49.4±43.9 pg/ml, P = 0.001 and worse left ventricle [LV] function: ejection fraction: 53.2±6.7 versus 57.3±5.5%, P < 0.0001; LV diastolic diameter: 4.86±0.52 versus 4.66±0.5 cm, P < 0.01.
CONCLUSION: Predominant RVP in patients without symptoms of HF at baseline may be responsible for worse performance in cardiopulmonary exercise test, higher BNP concentrations and impairment of LV function. Specific DDDR pacemaker programming promotes intrinsic AV conduction and may prevent the development of pacing-induced HF. ©2013, Wiley Periodicals, Inc.

Entities:  

Keywords:  BNP; cardiopulmonary exercise; echocardiography; pacing; sinus node dysfunction

Mesh:

Substances:

Year:  2013        PMID: 23879277      PMCID: PMC6932429          DOI: 10.1111/anec.12049

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  25 in total

1.  Asynchronous electrical activation induces asymmetrical hypertrophy of the left ventricular wall.

Authors:  M F van Oosterhout; F W Prinzen; T Arts; J J Schreuder; W Y Vanagt; J P Cleutjens; R S Reneman
Journal:  Circulation       Date:  1998-08-11       Impact factor: 29.690

2.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

3.  The sick sinus syndrome in atrial disease.

Authors:  M I Ferrer
Journal:  JAMA       Date:  1968-10-14       Impact factor: 56.272

4.  Asymmetric thickness of the left ventricular wall resulting from asynchronous electric activation: a study in dogs with ventricular pacing and in patients with left bundle branch block.

Authors:  F W Prinzen; E C Cheriex; T Delhaas; M F van Oosterhout; T Arts; H J Wellens; R S Reneman
Journal:  Am Heart J       Date:  1995-11       Impact factor: 4.749

5.  Heart failure and echocardiographic changes during long-term follow-up of patients with sick sinus syndrome randomized to single-chamber atrial or ventricular pacing.

Authors:  J C Nielsen; H R Andersen; P E Thomsen; L Thuesen; P T Mortensen; T Vesterlund; A K Pedersen
Journal:  Circulation       Date:  1998-03-17       Impact factor: 29.690

6.  Multicenter, prospective, randomized safety and efficacy study of a new atrial-based managed ventricular pacing mode (MVP) in dual chamber ICDs.

Authors:  Michael O Sweeney; Kenneth A Ellenbogen; David Casavant; Robert Betzold; Todd Sheldon; Feng Tang; Megan Mueller; John Lingle
Journal:  J Cardiovasc Electrophysiol       Date:  2005-08

7.  Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.

Authors:  Bruce L Wilkoff; James R Cook; Andrew E Epstein; H Leon Greene; Alfred P Hallstrom; Henry Hsia; Steven P Kutalek; Arjun Sharma
Journal:  JAMA       Date:  2002-12-25       Impact factor: 56.272

8.  Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome.

Authors:  H R Andersen; J C Nielsen; P E Thomsen; L Thuesen; P T Mortensen; T Vesterlund; A K Pedersen
Journal:  Lancet       Date:  1997-10-25       Impact factor: 79.321

9.  Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality.

Authors:  M Rosenqvist; J Brandt; H Schüller
Journal:  Am Heart J       Date:  1988-07       Impact factor: 4.749

10.  Ventricular pacing or dual-chamber pacing for sinus-node dysfunction.

Authors:  Gervasio A Lamas; Kerry L Lee; Michael O Sweeney; Russell Silverman; Angel Leon; Raymond Yee; Roger A Marinchak; Greg Flaker; Eleanor Schron; E John Orav; Anne S Hellkamp; Stephen Greer; John McAnulty; Kenneth Ellenbogen; Frederick Ehlert; Roger A Freedman; N A Mark Estes; Arnold Greenspon; Lee Goldman
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.